| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2018 | 8.07 | 8.07 | 8.07 | 8.50 | 45,000 |
| Oct 18, 2018 | 8.61 | 8.61 | 8.61 | 8.50 | 11,614 |
| Oct 17, 2018 | 8.61 | 8.61 | 8.61 | 8.50 | 7,166 |
| Oct 16, 2018 | 8.02 | 8.05 | 8.02 | 8.50 | 10,763 |
| Oct 15, 2018 | 8.02 | 8.58 | 8.00 | 8.50 | 26,586 |
| Name | Tissue Regenix Group | Epic | TRX |
|---|---|---|---|
| ISIN | GB00B5SGVL29 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 15,000 | Prev Close | 8.50 |
| Shares in Issue (m) | 1,171.73 | Market Cap (£m) | 99.60 |
| PE Ratio | -8.50 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -1.00 | EPS Growth (%) | 22.48 |
| PEG | -0.38 | DPS Growth (%) | n/a |
| ROCE | -26.28 | Net Gearing | -22.25 |
| Quick Ratio | 4.31 | Current Ratio | 4.91 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 21 Jul | Jefferies International | Buy | 8.50 | 39.00 | 39.00 | Reiterates |
| 05 Jun | Beaufort Securities | Speculative Buy | 8.50 | - | - | Retains |
| 13 Oct | Beaufort Securities | Speculative Buy | 8.50 | - | - | Retains |
| 02 Sep | Beaufort Securities | Speculative Buy | 8.50 | - | - | Retains |
| 12 Jul | Beaufort Securities | Speculative Buy | 8.50 | - | - | Retains |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 09 Aug 2017 | John Samuel | Buy | 2,000,000 @ 10.00p | £200,000.00 |
| 09 Aug 2017 | Alan Miller | Buy | 1,000,000 @ 10.00p | £100,000.00 |
| 09 Aug 2017 | Antony Odell | Buy | 150,000 @ 10.00p | £15,000.00 |
| 09 Aug 2017 | Jonathan Glenn | Buy | 600,000 @ 10.00p | £60,000.00 |
| 09 Aug 2017 | Steven Couldwell | Buy | 300,000 @ 10.00p | £30,000.00 |
